nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.19	0.672	CbGbCtD
Ethanolamine Oleate—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.093	0.329	CbGbCtD
Ethanolamine Oleate—F12—Intrinsic Pathway—KNG1—peripheral nervous system neoplasm	0.0274	0.152	CbGpPWpGaD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—CD55—peripheral nervous system neoplasm	0.0266	0.148	CbGpPWpGaD
Ethanolamine Oleate—Disseminated intravascular coagulation—Isotretinoin—peripheral nervous system neoplasm	0.0214	0.0449	CcSEcCtD
Ethanolamine Oleate—Disseminated intravascular coagulation—Tretinoin—peripheral nervous system neoplasm	0.0214	0.0449	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.0211	0.117	CbGpPWpGaD
Ethanolamine Oleate—Oesophageal ulcer—Tretinoin—peripheral nervous system neoplasm	0.021	0.0439	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Isotretinoin—peripheral nervous system neoplasm	0.021	0.0439	CcSEcCtD
Ethanolamine Oleate—F12—Formation of Fibrin Clot (Clotting Cascade)—KNG1—peripheral nervous system neoplasm	0.0185	0.103	CbGpPWpGaD
Ethanolamine Oleate—FABP5—tongue—peripheral nervous system neoplasm	0.0172	0.44	CbGeAlD
Ethanolamine Oleate—Disseminated intravascular coagulation—Alitretinoin—peripheral nervous system neoplasm	0.0162	0.034	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Alitretinoin—peripheral nervous system neoplasm	0.0159	0.0333	CcSEcCtD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—KNG1—peripheral nervous system neoplasm	0.0125	0.0692	CbGpPWpGaD
Ethanolamine Oleate—FABP5—Teniposide—Etoposide—peripheral nervous system neoplasm	0.0103	0.499	CbGdCrCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.0102	0.0565	CbGpPWpGaD
Ethanolamine Oleate—Pleural effusion—Topotecan—peripheral nervous system neoplasm	0.0101	0.0211	CcSEcCtD
Ethanolamine Oleate—F12—trigeminal ganglion—peripheral nervous system neoplasm	0.01	0.257	CbGeAlD
Ethanolamine Oleate—Pleural effusion—Tretinoin—peripheral nervous system neoplasm	0.00999	0.0209	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Isotretinoin—peripheral nervous system neoplasm	0.00999	0.0209	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.0083	0.0174	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.0083	0.0174	CcSEcCtD
Ethanolamine Oleate—Ulcer—Isotretinoin—peripheral nervous system neoplasm	0.00809	0.0169	CcSEcCtD
Ethanolamine Oleate—Ulcer—Tretinoin—peripheral nervous system neoplasm	0.00809	0.0169	CcSEcCtD
Ethanolamine Oleate—Ulcer—Melphalan—peripheral nervous system neoplasm	0.00798	0.0167	CcSEcCtD
Ethanolamine Oleate—Necrosis—Dactinomycin—peripheral nervous system neoplasm	0.00797	0.0167	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Alitretinoin—peripheral nervous system neoplasm	0.00757	0.0159	CcSEcCtD
Ethanolamine Oleate—FABP4—parotid gland—peripheral nervous system neoplasm	0.00752	0.193	CbGeAlD
Ethanolamine Oleate—Oesophagitis—Isotretinoin—peripheral nervous system neoplasm	0.00699	0.0146	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Tretinoin—peripheral nervous system neoplasm	0.00699	0.0146	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Epirubicin—peripheral nervous system neoplasm	0.00695	0.0146	CcSEcCtD
Ethanolamine Oleate—Ulcer—Dactinomycin—peripheral nervous system neoplasm	0.00661	0.0139	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Doxorubicin—peripheral nervous system neoplasm	0.00643	0.0135	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Epirubicin—peripheral nervous system neoplasm	0.0063	0.0132	CcSEcCtD
Ethanolamine Oleate—Necrosis—Cisplatin—peripheral nervous system neoplasm	0.00629	0.0132	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.00629	0.0132	CcSEcCtD
Ethanolamine Oleate—Abscess—Cisplatin—peripheral nervous system neoplasm	0.00624	0.0131	CcSEcCtD
Ethanolamine Oleate—Ulcer—Alitretinoin—peripheral nervous system neoplasm	0.00613	0.0128	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Tretinoin—peripheral nervous system neoplasm	0.00601	0.0126	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Isotretinoin—peripheral nervous system neoplasm	0.00601	0.0126	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Melphalan—peripheral nervous system neoplasm	0.00594	0.0124	CcSEcCtD
Ethanolamine Oleate—Retrosternal pain—Doxorubicin—peripheral nervous system neoplasm	0.00583	0.0122	CcSEcCtD
Ethanolamine Oleate—Necrosis—Etoposide—peripheral nervous system neoplasm	0.00577	0.0121	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Dactinomycin—peripheral nervous system neoplasm	0.00571	0.012	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0056	0.0311	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00547	0.0304	CbGpPWpGaD
Ethanolamine Oleate—FABP5—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.00538	0.26	CbGdCrCtD
Ethanolamine Oleate—Oesophagitis—Alitretinoin—peripheral nervous system neoplasm	0.0053	0.0111	CcSEcCtD
Ethanolamine Oleate—Ulcer—Cisplatin—peripheral nervous system neoplasm	0.00522	0.0109	CcSEcCtD
Ethanolamine Oleate—FABP5—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	0.00498	0.241	CbGdCrCtD
Ethanolamine Oleate—Ulcer—Etoposide—peripheral nervous system neoplasm	0.00478	0.01	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00477	0.0265	CbGpPWpGaD
Ethanolamine Oleate—Renal failure acute—Alitretinoin—peripheral nervous system neoplasm	0.00456	0.00955	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Topotecan—peripheral nervous system neoplasm	0.00434	0.00909	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.00431	0.00904	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Tretinoin—peripheral nervous system neoplasm	0.0043	0.00902	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Isotretinoin—peripheral nervous system neoplasm	0.0043	0.00902	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Etoposide—peripheral nervous system neoplasm	0.00414	0.00866	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.00399	0.00836	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Cisplatin—peripheral nervous system neoplasm	0.00388	0.00814	CcSEcCtD
Ethanolamine Oleate—FABP5—cerebellum—peripheral nervous system neoplasm	0.00372	0.0954	CbGeAlD
Ethanolamine Oleate—FABP4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0036	0.02	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Dactinomycin—peripheral nervous system neoplasm	0.00352	0.00737	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Epirubicin—peripheral nervous system neoplasm	0.00331	0.00694	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.00326	0.00683	CcSEcCtD
Ethanolamine Oleate—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.00323	0.00677	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00323	0.0179	CbGpPWpGaD
Ethanolamine Oleate—Abscess—Epirubicin—peripheral nervous system neoplasm	0.00321	0.00672	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00314	0.00659	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Doxorubicin—peripheral nervous system neoplasm	0.00307	0.00642	CcSEcCtD
Ethanolamine Oleate—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.00299	0.00627	CcSEcCtD
Ethanolamine Oleate—Abscess—Doxorubicin—peripheral nervous system neoplasm	0.00297	0.00622	CcSEcCtD
Ethanolamine Oleate—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00287	0.00601	CcSEcCtD
Ethanolamine Oleate—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00285	0.00597	CcSEcCtD
Ethanolamine Oleate—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00285	0.00597	CcSEcCtD
Ethanolamine Oleate—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00281	0.00589	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00275	0.00577	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00275	0.00576	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.00273	0.0152	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00273	0.00572	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00273	0.00572	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00269	0.00564	CcSEcCtD
Ethanolamine Oleate—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.00268	0.00562	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.00265	0.0147	CbGpPWpGaD
Ethanolamine Oleate—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00255	0.00534	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.00255	0.00533	CcSEcCtD
Ethanolamine Oleate—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.00248	0.0052	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00244	0.0135	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00241	0.0134	CbGpPWpGaD
Ethanolamine Oleate—Pain—Topotecan—peripheral nervous system neoplasm	0.00235	0.00493	CcSEcCtD
Ethanolamine Oleate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00233	0.00489	CcSEcCtD
Ethanolamine Oleate—Pain—Tretinoin—peripheral nervous system neoplasm	0.00233	0.00489	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00486	CcSEcCtD
Ethanolamine Oleate—Pain—Melphalan—peripheral nervous system neoplasm	0.0023	0.00483	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00223	0.0124	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00217	0.00456	CcSEcCtD
Ethanolamine Oleate—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00216	0.00452	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00216	0.00452	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00216	0.00452	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	0.00214	0.00449	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00433	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00202	0.0112	CbGpPWpGaD
Ethanolamine Oleate—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.00199	0.00418	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00199	0.00418	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—GNAS—peripheral nervous system neoplasm	0.00195	0.0108	CbGpPWpGaD
Ethanolamine Oleate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00191	0.004	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—HGF—peripheral nervous system neoplasm	0.00186	0.0103	CbGpPWpGaD
Ethanolamine Oleate—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00185	0.00387	CcSEcCtD
Ethanolamine Oleate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00177	0.00371	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00176	0.00369	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00176	0.00369	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—GNS—peripheral nervous system neoplasm	0.00176	0.00978	CbGpPWpGaD
Ethanolamine Oleate—Pain—Vincristine—peripheral nervous system neoplasm	0.0017	0.00357	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—NME1—peripheral nervous system neoplasm	0.00169	0.00937	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00168	0.00353	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00343	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—COX2—peripheral nervous system neoplasm	0.00162	0.00902	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00161	0.00338	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.0016	0.00888	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00158	0.0033	CcSEcCtD
Ethanolamine Oleate—Pain—Cisplatin—peripheral nervous system neoplasm	0.00151	0.00316	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00299	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00292	CcSEcCtD
Ethanolamine Oleate—Pain—Etoposide—peripheral nervous system neoplasm	0.00138	0.00289	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.00136	0.00753	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00277	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—MET—peripheral nervous system neoplasm	0.00131	0.00726	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00128	0.00267	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00121	0.00671	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ENO2—peripheral nervous system neoplasm	0.00107	0.00592	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000955	0.0053	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000944	0.00198	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000905	0.0019	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—BCHE—peripheral nervous system neoplasm	0.000901	0.00501	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000874	0.00183	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00086	0.00477	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TH—peripheral nervous system neoplasm	0.000847	0.00471	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000837	0.00175	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000816	0.00453	CbGpPWpGaD
Ethanolamine Oleate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000774	0.00162	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.000727	0.00404	CbGpPWpGaD
Ethanolamine Oleate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000716	0.0015	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000715	0.0015	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—GNAS—peripheral nervous system neoplasm	0.000692	0.00384	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000679	0.00377	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000662	0.00139	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—TP53—peripheral nervous system neoplasm	0.000624	0.00346	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000597	0.00331	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.00057	0.0146	CbGeAlD
Ethanolamine Oleate—FABP4—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000532	0.00295	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000527	0.00293	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000469	0.00261	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000397	0.0022	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000268	0.00149	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	0.000194	0.00108	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—AKT1—peripheral nervous system neoplasm	0.000187	0.00104	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	0.000186	0.00103	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	0.000179	0.000994	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000117	0.000652	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	9.92e-05	0.000551	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.47e-05	0.000526	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	9.33e-05	0.000518	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	7.62e-05	0.000423	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	7.47e-05	0.000415	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	2.06e-05	0.000114	CbGpPWpGaD
